advertisement
11.4 Prostaglandins (24)
Showing records 1 to 24
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
Kestelyn PA
International Ophthalmology 2017; 0:
75462 Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma
Mahar PS
International Ophthalmology 2017; 0:
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Weinreb RN
Journal of Glaucoma 2018; 27: 7-15
75368 Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects
Ra S
PLoS ONE 2017; 12: e0188534
75439 Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
Holló G
Drugs 2018; 78: 39-64
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Aizawa N; Kunikata H
PLoS ONE 2017; 12: e0188692
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Liebmann JM
Journal of Glaucoma 2018; 27: 7-15
75439 Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
Katsanos A
Drugs 2018; 78: 39-64
75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
Kestelyn PG
International Ophthalmology 2017; 0:
75462 Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma
Butt NH
International Ophthalmology 2017; 0:
75368 Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects
Ayaki M; Yuki K
PLoS ONE 2017; 12: e0188534
75439 Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
Boboridis KG
Drugs 2018; 78: 39-64
75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
De Bacquer D
International Ophthalmology 2017; 0:
75462 Efficacy of locally produced Latanoprost in the control of intraocular pressure in patients with primary open-angle glaucoma
Ali SI
International Ophthalmology 2017; 0:
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Martin KR
Journal of Glaucoma 2018; 27: 7-15
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Shiga Y
PLoS ONE 2017; 12: e0188692
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Kaufman PL
Journal of Glaucoma 2018; 27: 7-15
75597 Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients
Stevens AM
International Ophthalmology 2017; 0:
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Tsuda S
PLoS ONE 2017; 12: e0188692
75368 Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects
Tsubota K
PLoS ONE 2017; 12: e0188534
75439 Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages
Irkec M; Konstas AGP
Drugs 2018; 78: 39-64
75368 Dry eye, sleep quality, and mood status in glaucoma patients receiving prostaglandin monotherapy were comparable with those in non-glaucoma subjects
Negishi K
PLoS ONE 2017; 12: e0188534
75428 Latanoprostene Bunod 0.024% in Subjects With Open-angle Glaucoma or Ocular Hypertension: Pooled Phase 3 Study Findings
Vittitow JL
Journal of Glaucoma 2018; 27: 7-15
75509 Preperimetric Glaucoma Prospective Observational Study (PPGPS): Design, baseline characteristics, and therapeutic effect of tafluprost in preperimetric glaucoma eye
Yokoyama Y; Omodaka K; Yasui T; Kato K; Kurashima H; Miyamoto E; Hashimoto M; Nakazawa T
PLoS ONE 2017; 12: e0188692
